Medtronic reported $37.5B of revenue over the trailing twelve months, +9.8% on the year before. 11 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $37.5B (to Q1 2027). Net income: $5.23B, trailing twelve months to Q1 2027. Free cash flow: $6.13B, trailing twelve months to Q1 2027. Operating margin: 18%, trailing twelve months to Q1 2027.

MDTMedtronic

Healthcare

$88.48-5.3% 1Y

$88.48

$73.7552 weeks$103.73

MDT as reported

Medtronic reported $37.5B of revenue over the trailing twelve months, +9.8% on the year before. 11 reported series are charted on this page, each one as filed.

$37.5B

Revenue, trailing twelve months · to Q1 2027 · +9.8% against the twelve months before

Net income: $5.23B
Net income · +12% year on year · trailing twelve months to Q1 2027
Free cash flow: $6.13B
Free cash flow · +16% year on year · trailing twelve months to Q1 2027
Operating margin: 18%
Operating margin · trailing twelve months to Q1 2027

Details›

Every series Ryufin has for MDT, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$37.5B	+9.8%	Q1 2027
Net income	$5.23B	+12%	Q1 2027
EPS	$4.07	+12%	Q1 2027
Gross margin	65%	n/a	Q1 2027
Operating margin	18%	n/a	Q1 2027
Net margin	14%	n/a	Q1 2027
ROE	9.8%	n/a	Q1 2027
ROA	5.3%	n/a	Q1 2027
ROIC	7.3%	n/a	Q1 2027
Free cash flow	$6.13B	+16%	Q1 2027
P/E	21.7	n/a	today

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.